Neuronetics Inc (STIM)
1.14
+0.04
(+4.11%)
USD |
NASDAQ |
Nov 05, 16:00
1.14
0.00 (0.00%)
After-Hours: 16:10
Neuronetics Shareholders Equity (Quarterly): 19.39M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 19.39M |
March 31, 2024 | 27.66M |
December 31, 2023 | 34.19M |
September 30, 2023 | 37.94M |
June 30, 2023 | 45.48M |
March 31, 2023 | 48.34M |
December 31, 2022 | 57.06M |
September 30, 2022 | 62.99M |
June 30, 2022 | 68.42M |
March 31, 2022 | 76.60M |
December 31, 2021 | 85.18M |
September 30, 2021 | 91.08M |
June 30, 2021 | 97.17M |
March 31, 2021 | 101.97M |
Date | Value |
---|---|
December 31, 2020 | 25.49M |
September 30, 2020 | 27.48M |
June 30, 2020 | 29.44M |
March 31, 2020 | 36.51M |
December 31, 2019 | 47.85M |
September 30, 2019 | 54.33M |
June 30, 2019 | 59.82M |
March 31, 2019 | 65.42M |
December 31, 2018 | 71.04M |
September 30, 2018 | 76.35M |
June 30, 2018 | -205.27M |
March 31, 2018 | -10.35M |
December 31, 2017 | -192.65M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
19.39M
Minimum
Jun 2024
101.97M
Maximum
Mar 2021
53.70M
Average
47.85M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
Quest Diagnostics Inc | 6.809B |
Delcath Systems Inc | 4.192M |
Star Equity Holdings Inc | 58.44M |
CytoSorbents Corp | 16.74M |
Progyny Inc | 456.19M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 96.81M |
Total Liabilities (Quarterly) | 77.43M |
Debt to Equity Ratio | 3.082 |
Current Ratio | 2.581 |
Net Debt Paydown Yield | -8.52% |